← Back to headlines
Mineralys Therapeutics Reports Q4 GAAP EPS Beat
Mineralys Therapeutics announced a GAAP EPS of -$0.40 for the fourth quarter, beating analyst estimates by $0.13.
12 Mar, 20:36 — 12 Mar, 20:36
Sources
Showing 1 of 1 sources
Related Stories
Gold continues lackluster showing since start of Iran war while oil keeps climbing
21m ago
Wall Street Traders Hunt for Bottom as War Turmoil Continues - Bloomberg.com
45m ago
Greek Economy Growth Forecast Tied to Middle East Conflict
47m ago
Germany Fails to Sell Full Volume of Bonds Amid Investor Caution
47m ago